EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Renal Injury and Dysfunction among HIV Positive Patients Receiving Tenofovir Based Anti-Retroviral Therapy

Wasin Bunpeth, Ouppatham Supasyndh, Bancha Satirapoj

Journal of Southeast Asian Medical Research · 2017

DOI: 10.55374/jseamed.v1i1.34 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Southeast Asian Medical Research, 2017. Verfasst von Wasin Bunpeth und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rate of renal disease among patients with HIV has decreased significantly since the introduction of highly active antiretroviral therapy (HAART). Patients receiving tenofovir, disoproxil, fumarate (TDF) had an increased prevalence of proximal renal tubular dysfunction and injury but its clinical significance remain controversial. To difine the renal tubulopathy injury among patients with HIV with and without TDF. A cross-sectional study was conducted among HIV positive patients receiving TDF (N= 176) and non TDF regimen (N= 146) at outpatient clinic. All patients were evaluated regarding serum creatinine, electrolytes, phosphate and differing urinary parameters (proteinuria, glycosuria and pyuria). Estimated glomerular filtration rate (GFR) was calculated using CKD-EPI equation. Of 322 participants with mean age of 41.6+-11.4 years and HIV duration of 7.2+-4.3 years, the TDF and non TDF groups were similar on most clinical and demographic factors. GFR was 100.6+- 17.8 mL/min/1.73 m2 in TDF group and 97.5+- 19.6 mL/min/1.73 m2 in non-TDF group (p= 0.143). During evaluation, 3.4% of TDF patients vs. none of the non TDF-patients had hypophosphataemia (< 2.5 mg/dL), 3.9% of TDF-patients vs. 1.3% of non TDF had hypokalemia (< 3.5 mg/dL), and 0.68% of TDF-patients vs. none of non TDF patients had acidosis (< 18 mEq/L) with no statistically significant difference between groups. The proportion of patients with evidence of urine abnormalities was also similar in the two groups (Dipstick proteinuria > 1+, TDF: 17.6% vs. non-TDF 20.5%, p= 0.568, and pyuria; TDF: 27.3% vs. non TDF 20.5%, p= 0.192). Renal impairment, electrolyte disturbances and renal tubulopathy were uncommon among HIV positive patients receiving TDF-based antiretroviral therapy and did not significantly differ between TDF and non TDF regimens

Zitieren

APA

Bunpeth, W., Supasyndh, O., & Satirapoj, B. (2017). Renal Injury and Dysfunction among HIV Positive Patients Receiving Tenofovir Based Anti-Retroviral Therapy. Journal of Southeast Asian Medical Research. https://doi.org/10.55374/jseamed.v1i1.34

Vancouver

Bunpeth W, Supasyndh O, Satirapoj B. Renal Injury and Dysfunction among HIV Positive Patients Receiving Tenofovir Based Anti-Retroviral Therapy. Journal of Southeast Asian Medical Research. 2017. doi:10.55374/jseamed.v1i1.34

BibTeX
@article{Bunpeth2017,
  author = {Bunpeth, Wasin and Supasyndh, Ouppatham and Satirapoj, Bancha},
  title = {Renal Injury and Dysfunction among HIV Positive Patients Receiving Tenofovir Based Anti-Retroviral Therapy},
  journal = {Journal of Southeast Asian Medical Research},
  year = {2017},
  doi = {10.55374/jseamed.v1i1.34}
}
Kostenlos starten →